Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?

Tolerogenic dendritic cells (tolDCs) are explored as a promising standalone or combination therapy in type 1 diabetes (T1D). The therapeutic application of tolDCs, including in human trials, has been tested also in other autoimmune diseases, however, T1D displays some unique features. In addition, u...

Descripción completa

Detalles Bibliográficos
Autores principales: Funda, David P., Palová-Jelínková, Lenka, Goliáš, Jaroslav, Kroulíková, Zuzana, Fajstová, Alena, Hudcovic, Tomáš, Špíšek, Radek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527741/
https://www.ncbi.nlm.nih.gov/pubmed/31139178
http://dx.doi.org/10.3389/fimmu.2019.00967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527741/
https://www.ncbi.nlm.nih.gov/pubmed/31139178
http://dx.doi.org/10.3389/fimmu.2019.00967

Ejemplares similares